On the HCPLive Internal Medicine condition center page, resources on the topics of medical news and expert insight into internal medicine can be found. Content includes articles, interviews, videos, podcasts, and breaking news on internal medicine research, treatment, and drug development.
April 21st 2024
Data presented at ACP 2024 shows non-White patients may be particularly subjected to more risk of discrimination in their care when ED boarding extends past 24 hours.
The Latest on Acute Lymphocytic Leukemia
View More
A Focus on Acute Myeloid Leukemia
View More
Updates in Myelodysplastic Syndromes
View More
Earn CME Credits While Advancing Your Expertise in Internal Medicine
April 18-19, 2024
Register Now!
Gene Therapy for Hemophilia B—The Next Step Forward in Disease Management
View More
Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes
View More
Revolutionizing Early-Stage NSCLC Treatment: Pathologists’ Key Insights into Predicting Pathologic Responses to Immunotherapies
View More
BURST Expert Illustrations & Commentaries™: A Closer Look at the Role of Complement Inhibitors in the Treatment of Paroxysmal Nocturnal Hemoglobinuria
View More
Medical Crossfire®: How Have HER2-Low Expressing Breast Cancers and Novel Advances in the Field Redefined Care As We Knew It?
View More
Community Practice Connections™: What’s Next for Patients with Breast Cancer, and How Can We Effectively Optimize PARP-, HER2/3-, and TROP2-Targeted Regimens in Treatment Plans?
View More
Community Practice Connections™: 20th Annual Winter Lung Conference
View More
Show Me Your Care Plan™: Nursing Considerations for Applying the Latest Approaches Across Care Settings in Melanoma
View More
Patient, Provider and Caregiver Connection™: Addressing Patient Concerns During the Treatment and Management of HR+/HER2- Breast Cancer
View More
Show Me Your Care Plan: Nursing Considerations for Managing Breast Cancer Patients
View More
Medical Crossfire®: Key Strategies to Prioritize Testing and the Evolving Role of Genomic Alterations in Providing Precision NSCLC Care
View More
Community Practice Connections™: The Newest Frontier in HR+ Breast Cancer—Targeting ESR1 Mutations with Next-Generation Endocrine Therapy
View More
Breaking Down Biomarkers in Non–Small Cell Lung Cancer: A Case-Based Discussion for the Oncology Nurse
View More
Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs
View More
Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy
View More
Community Practice Connections™: 16th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies
View More
Clinical Case Vignette Series™: 40th Annual Miami Breast Cancer Conference®
View More
Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma
View More
Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis
View More
Go To PER in Chicago
May 31, 2024 - June 2, 2024
Register Now!
Evaluating the Recent Advancements in Chronic Kidney Disease Treatment: A Case-Based Approach to Managing CKD and Related Comorbidities
View More
The Top 10 Oncogenic Drivers in NSCLC for 2023: What You Need to Know on Tumor Testing, Targets, and Treatment Strategies to Move the Field Forward
View More
Patient, Provider, and Caregiver Connection™: Individualizing Care for Patients with Schizophrenia—Understanding Patient Challenges and the Role of Innovative Treatment
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
Expert Illustrations & Commentaries™: Exploring the Mechanistic Rationale for Targeting FGFR2 and Pan-FGFR in CCA
View More
Oncology Town Hall™: Primary Investigators Present Key Abstracts in Multiple Myeloma from the Summer Meetings
View More
In Hemodialysis Patients, Renin-Angiotensin System Inhibitors Reduce All-Cause Mortality Risk
November 9th 2013A recent study found that drug regimens containing renin-angiotensin system (RAS) inhibitors are associated with a lower risk of cardiovascular and all-cause deaths among patients starting hemodialysis, compared to regimens containing only beta blockers (BBs).
Preventative Measures for Upper Gastrointestinal Tract Bleeding
Primary prevention measures for upper GI bleeding should include NSAIDs, antiplatelet therapy, and anticoagulants appropriately, while secondary preventive measures should include testing and treating H. pylori and using long-term PPIs when appropriate.
New Oral Anticoagulants Carry Risks and Benefits in Venous Thromboembolism
In his "Venous Thromboembolism: New Evidence and Best Practice" presentation, Steven Deitelzweig, MD, a hospitalist at Ochsner Medical Center, reviewed new oral anticoagulants (NOACs) used to treat venous thromboembolism (VTE).
Hyponatremia Produces Poor Outcomes in Acute-on-Chronic Liver Failure
November 6th 2013Drawing upon data from a large European study, Andrés Cárdenas, MD, reported an association between hyponatremia and acute-on-chronic liver failure (ACLF) during a poster session at the 2013 annual meeting of the American Association for the Study of Liver Diseases held November 1-5, 2013, in Washington, DC.
Hyponatremia Correction in Cirrhosis May Improve Cognition, Reduce Caregiver Burden
November 6th 2013Investigating the association between hyponatremia and cognition in patients with cirrhosis, Jasmohan Bajaj, MD, and colleagues from Virginia Commonwealth University presented results showing reduced brain edema, better quality of life (QOL), and less caregiver burden with the use of the aquaretic tolvaptan.
Investigational Antiviral Offers Benefit in Patients Co-Infected with Hepatitis C, HIV
November 6th 2013A novel direct-acting antiviral (DAA) targeting a protein associated with hepatitis C (HCV) also has antiviral activity against HIV-1 and shows benefit in co-infected individuals when added to pegylated interferon and ribavirin treatment (PR).
12 Weeks Post-Treatment Is Appropriate Endpoint for Measuring Response to Hepatitis C Regimen
November 5th 2013Emerging data from a clinical trial on triple direct-acting antiviral (DAA) therapy plus ribavirin (RBV) in hepatitis C (HCV) genotype 1 (GT1) patients shows that the low rate of relapse during and after treatment leads to high concordance rates between measurements of sustained viral response (SVR) at 4, 12, and 24 weeks post-treatment.
Aggressive Cardiac Rehabilitation Improves Outcomes in Chronic Heart Failure Patients
November 1st 2013Results of a randomized controlled trial demonstrate that a long-term, supervised, moderate-intensity exercise training program for chronic heart failure patients can produce improvements in hospital readmission and survival rates.
Discussing Healthful Eating and Weight with Obese Adolescents
November 1st 2013Conversations about healthful eating between parents and students are associated with a lower prevalence of disordered eating behaviors in adolescents, while conversations about weight result in a higher prevalence of those behaviors.
Bronchial Thermoplasty Offers Long-Term Benefits for Some Refractory Asthma Patients
October 31st 2013Guidelines to be released later this year by the American Thoracic Society (ATS) and the European Respiratory Society (ERS) suggest that bronchial thermoplasty may be an effective treatment for moderate to severe asthma patients, for whom inhaled corticosteroids have provided unsatisfactory results.
Meniscus Extrusion Predicts Radiographic Osteoarthritis Change Better Than Cartilage Volume Loss
Although change in knee joint space narrowing depicted on radiographs is considered the gold standard for monitoring osteoarthritis progression and knee cartilage volume loss, the method doesn't account for extrusion of the medial meniscus, which new research suggests can better predict radiographic osteoarthritis change over time.
Biologics Beat Triple DMARDs Therapy on Cost, But No Winner in Debate on Efficacy, Safety in RA
During their "Great Debate" keynote session of the American College of Rheumatology (ACR) 2013 Annual Meeting in San Diego, CA, two leading rheumatologists took direct aim at each other's significant clinical trial data to provide rationale for choosing biologics over triple therapy - or vice versa - as the treatment of choice for rheumatoid arthritis (RA).
Tocilizumab Treatment Associated with Cardiovascular Improvements in RA Patients
Though rheumatoid arthritis (RA) patients have a significantly higher risk of developing cardiovascular disease (CVD) compared to the general population, results from a pair of studies show that the biologic disease modifier Actemra (tocilizumab) may actually improve the cardiovascular (CV) profiles of RA patients.
FDA Continues Investigation of MS Drug
The US Food and Drug Administration (FDA) is continuing to investigate a potential link between Novartis's multiple sclerosis (MS) drug Gilenya (fingolimod) and a single case of a rare and serious brain infection in a European patient.
5-Year Efficacy Data Shows Golimumab Yields Long-Term RA Improvements
As a follow-up to the initial establishment of Simponi (golimumab)'s safety and efficacy in rheumatoid arthritis (RA), researchers presented final 5-year data evaluating the tumor necrosis factor (TNF) blocker's effects in RA patients taking methotrexate and those naïve to the biologic agent.
Smoking Cessation and Off-Label Therapies May Be Most Potent Treatment for COPD Exacerbations
October 29th 2013Doctors treating patients for COPD exacerbations may have recourse to a variety of treatments, including some off-label applications of existing drugs, and smoking cessation may result in a reduction of repeat occurrences.